OFM
Omega Fund Management Portfolio holdings
AUM
$154M
1-Year Return
32.78%
This Quarter Return
+6.68%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$154M
AUM Growth
-$15M
(-8.9%)
Cap. Flow
-$6.44M
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
97.77%
Holding
13
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Nuvation Bio
NUVB
|
+$3.96M |
| 2 |
KMTS
Kestra Medical Technologies, Ltd. Common Stock
KMTS
|
+$2.49M |
Sector Composition
| 1 | Healthcare | 99.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics, Inc. Common Stock
BBNX
$1.08B
| $28.9M | 18.75% |
1,988,287
| – | – |
|
|
KMTS
2
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$949M
| $27.3M | 17.67% |
1,645,893
-150,000
| -8% | -$2.49M |
|
|
UPB
3
Upstream Bio, Inc. Common Stock
UPB
$969M
| $22.4M | 14.48% |
2,036,293
| – | – |
|
|
4
Nuvation Bio
NUVB
$1.14B
| $21.5M | 13.94% |
11,042,728
-2,029,612
| -16% | -$3.96M |
|
|
BCAX
5
Bicara Therapeutics Inc. Common Stock
BCAX
$667M
| $20.5M | 13.26% |
2,204,650
| – | – |
|
6
Replimune Group
REPL
$450M
| $18.3M | 11.88% |
1,975,203
| – | – |
|
7
Lexeo Therapeutics
LXEO
$288M
| $4.76M | 3.08% |
1,184,636
| – | – |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$99.4M
| $3.01M | 1.95% |
187,427
| – | – |
|
9
Sana Biotechnology
SANA
$752M
| $2.3M | 1.49% |
843,750
| – | – |
|
|
ALMS
10
Alumis Inc. Common Stock
ALMS
$458M
| $1.96M | 1.27% |
653,223
| – | – |
|
11
enGene Holdings
ENGN
$326M
| $1.92M | 1.24% |
526,357
| – | – |
|
12
Immunic
IMUX
$87.3M
| $1.25M | 0.81% |
1,788,160
| – | – |
|
|
13
enGene Holdings Inc. Warrants
ENGNW
$7.7M
| $273K | 0.18% |
321,502
| – | – |
|